PRF1 and rheumatoid arthritis: A recent study on target cells engineered to express PAD2 or PAD4, two key citrullinating enzymes strongly implicated in RA pathogenesis and highly expressed by neutrophils, demonstrated a combinatorial effect of perforin and granzymes on the creation of autoantigens recognized by sera from RA patients (101).